NYU Langone Health: Opioid-Related Disorders trials

The registry lists 22 Opioid-Related Disorders studies with NYU Langone Health as lead sponsor. 4 are open to participants now and 9 have results posted.

Phase 1 1Phase 2 3Phase 3 2Phase 4 7No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Psilocybin for Opioid Use Disorder (OUD)RecruitingNCT06796062Phase 2
• Assessing Optimal XRB Initiation Points in JailRecruitingNCT06051890Phase 4
• E-Cigarettes for Harm Reduction in Smokers With Opioid Use DisorderRecruitingNCT05722561Phase 2
• Smartphones for Opiate Addiction RecoveryRecruitingNCT05033028Phase 3
• Emergency Department Outcomes for Patients With Opioid Use DisorderCompletedNCT04289363Results posted
• Buprenorphine Loading in the Emergency DepartmentCompletedNCT04283500Phase 4Results posted
• Subthreshold Opioid Use Disorder Prevention (STOP) TrialCompletedNCT04218201Not applicableResults posted
• XRB vs. SLB in Jail and at Re-entry: Pilot, Proof of ConceptCompletedNCT03604159Phase 4Results posted
• TAU Opioid Use Outcomes Following Discharge From Detoxification and Short Term Residential Programs Affiliated With CTN-0051CompletedNCT02730403Results posted
• Comparing Interventions for Opioid Dependent Patients Presenting in Medical Emergency DepartmentsCompletedNCT02586896Not applicableResults posted
• Extended-Release Naltrexone vs. Buprenorphine for Opioid TreatmentCompletedNCT02032433Phase 4Results posted
• Extended-Release Naltrexone Opioid Treatment at Jail Re-EntryCompletedNCT01999946Phase 4Results posted
• Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From JailCompletedNCT01180647Phase 3Results posted
• Assessing Optimal XR-Buprenorphine Initiation Points in JailWithdrawnNCT05481112Phase 4
• ED Observation for Opioid Use DisorderActive, not recruitingNCT05064826Not applicable
• Coaching Performance Driven Practice Change in the Context of Value Based Purchasing Under New York MedicaidCompletedNCT04632238Not applicable
• Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)Active, not recruitingNCT04464980Phase 2
• Long-acting Buprenorphine vs. Naltrexone Opioid Treatments in CJS-involved AdultsCompletedNCT04219540Phase 4
• Needle-X: Usability Testing of a Smartphone ApplicationWithdrawnNCT03665298Not applicable
• A Pragmatic Trial of the Consult for Addiction Treatment and Care in Hospitals (CATCH) Model for Engaging Patients in Opioid Use Disorder TreatmentCompletedNCT03611335
• Emergency Department Connection to Care With Buprenorphine for Opioid Use DisorderCompletedNCT03544112
• Aprepitant Effects in Intravenous Heroin DependenceCompletedNCT01527994Phase 1